MicroQuin: hunting down breast cancer

Working with two complementary technologies, biotech company MicroQuin is developing next-generation targeted therapies that kill all breast cancers with no toxicity.

Like 2 Comment
Page of
Go to the profile of Microquin


Founded in London (United Kingdom) in 2016, MicroQuin was born out of a collaborative and inclusive approach to research. MicroQuin is a biotechnology, R&D based company currently focusing on developing therapeutics to address a range of oncological disease. MicroQuin is progressing lead compounds into clinical trials, which offer a potential cure to Breast Cancer and other diseases.

No comments yet.